Bluefin Capital Management’s AstraZeneca AZN Stock Holding History

Bluefin Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,231	Closed	-$842K	–	685
2021 Q4	$842K	Buy	7,231 +231	+3%	+$27.2K	0.06%	247
2021 Q3	$841K	Sell	7,000 -1,262	-15%	-$147K	0.08%	179
2021 Q2	$990K	Sell	8,262 -688	-8%	-$75.5K	0.06%	189
2021 Q1	$890K	Buy	+8,950	New	+$900K	0.04%	209
2020 Q3	–	Hold	0	–	–	–	181
2019 Q1	–	Sell	-4,450	Closed	-$338K	–	404
2018 Q4	$338K	Sell	4,450 -250	-5%	-$19.5K	0.03%	196
2018 Q3	$372K	Buy	4,700 +1,350	+40%	+$102K	0.03%	252
2018 Q2	$235K	Buy	3,350 +150	+5%	+$10.8K	0.02%	274
2018 Q1	$224K	Buy	3,200 +50	+2%	+$3.46K	0.02%	265
2017 Q4	$219K	Hold	3,150	–	–	0.01%	341
2017 Q3	$213K	Buy	+3,150	New	+$199K	0.03%	318
2017 Q1	–	Sell	-4,900	Closed	-$268K	–	476
2016 Q4	$268K	Buy	+4,900	New	+$278K	0.02%	292
2016 Q3	–	Sell	-19,969	Closed	-$1.21M	–	442
2016 Q2	$1.21M	Buy	+19,969	New	+$1.16M	0.12%	129
2015 Q1	–	Sell	-7,572	Closed	-$533K	–	428
2014 Q4	$533K	Sell	7,572 -433,561	-98%	-$31M	0.03%	340
2014 Q3	$31.5M	Buy	441,133 +110,880	+34%	+$8.12M	1.73%	6
2014 Q2	$24.5M	Buy	330,253 +323,508	+4,796%	+$23.4M	1.05%	9
2014 Q1	$400K	Buy	+6,745	New	+$436K	0.03%	340

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Bluefin Capital Management's AZN Position: Q1 2022 in Review

Bluefin Capital Management sold out of AstraZeneca (AZN) in Q1 2022, closing a stake of 7,231 shares — an estimated $842K sold.

Bluefin Capital Management first reported a position in AZN in Q1 2014 and held it in 16 quarters. The position peaked at $31.5M in Q3 2014. 982 funds tracked by Wall St. Rank hold AZN as of Q1 2022.

Bluefin Capital Management reported no remaining AstraZeneca position as of Q1 2022 after selling out during the quarter.
Bluefin Capital Management sold 7,231 AstraZeneca shares in Q1 2022, an estimated $842K.
Bluefin Capital Management first reported a position in AstraZeneca in Q1 2014 and held it in 16 quarters.
Bluefin Capital Management's AstraZeneca position peaked at $31.5M in Q3 2014.
982 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.